Filing Flows › Profound Medical (PROF) › Recalls, complaints & regulation
Profound Medical (PROF): clinical trials
Profound Medical (PROF) beyond its filings: 3 active clinical trials.
Profound Medical's latest quarter
Profound Medical, Q3 2026: revenue $9.8M (+86% year over year), operating margin -79.6%, net loss $7.7M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Profound Medical have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.